Search

• An average case fatality ratio over the first six months after the outbreak of COVID-19 in Poland was 5.43% (95% CI: 5.08% – 5.73%), while among hospitalized cases 16.9% (15.8% – 17.9%). • The case fatality rate had a decreasing trend in time starting from 7.83% (7.08% – 8.61%) during first eight weeks after the outbreak (March – April), to reach 2.52% (2.06% – 3.02%) during the summer season (July – August). • Recent medical care as well as the identification of the source contact, independently of the age, sex and comorbidities, significantly impact an individual mortality risk. After more than one and a half year since the COVID-19 pandemics outbreak the scientific world is constantly trying to understand its dynamics. In this paper of the case fatality rates (CFR) for COVID-19 we study the historic data regarding mortality in Poland during the first six months of pandemic, when no SARS-CoV-2 variants of concern were present among infected. To this end, we apply competing risk models to perform both uni- and multivariate analyses on specific subpopulations selected by different factors including the key indicators: age, sex, hospitalization. The study explores the case fatality rate to find out its decreasing trend in time. Furthermore, we describe the differences in mortality among hospitalized and other cases indicating a sudden increase of mortality among hospitalized cases at the end of the 2020 spring season. Exploratory and multivariate analysis revealed the real impact of each variable and besides the expected factors indicating increased mortality (age, comorbidities) we track more non-obvious indicators. Recent medical care as well as the identification of the source contact, independently of the comorbidities, significantly impact an individual mortality risk. As a result, the study provides a twofold insight into the COVID-19 mortality in Poland. On one hand we explore mortality in different groups with respect to different variables, on the other we indicate novel factors that may be crucial in reducing mortality. The later can be coped, e.g. by more efficient contact tracing and proper organization and management of the health care system to accompany those who need medical care independently of comorbidities or COVID-19 infection. [ABSTRACT FROM AUTHOR]